Catalyst Funds Management Pty LTD Allakos Inc. Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Allakos Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 13,600 shares of ALLK stock, worth $3,943. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,600
Previous 13,600
-0.0%
Holding current value
$3,943
Previous $8.88 Million
85.23%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALLK
# of Institutions
79Shares Held
68.8MCall Options Held
20.9KPut Options Held
0-
Bvf Inc San Francisco, CA16.6MShares$4.8 Million0.75% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$1.78 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.7MShares$1.65 Million0.3% of portfolio
-
Lynx1 Capital Management LP San Juan, PR3.63MShares$1.05 Million1.7% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.04 Million0.01% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $24.6M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...